0001213900-11-003382.txt : 20110624
0001213900-11-003382.hdr.sgml : 20110624
20110624191816
ACCESSION NUMBER: 0001213900-11-003382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110622
FILED AS OF DATE: 20110624
DATE AS OF CHANGE: 20110624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZELDIS JEROME B
CENTRAL INDEX KEY: 0001433982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16929
FILM NUMBER: 11931642
MAIL ADDRESS:
STREET 1: 8767 E. VIA DE VENTURA, SUITE 190
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
f4062211zeldis_soligenix.xml
FORM 4
X0303
4
2011-06-22
0
0000812796
SOLIGENIX, INC.
SNGX
0001433982
ZELDIS JEROME B
29 EMMONS DRIVE
SUITE C-10
PRINCETON
NJ
08540
1
0
0
0
Stock Option (Right to Buy)
0.199
2011-06-22
4
A
0
300000
0
A
2011-06-22
2021-06-22
Common Stock
300000
300000
D
The option vested immediately as to all 300,000 shares. The exercise price of the option equals $0.199 per share, the market price of the Company's common stock as of the close of business on June 22, 2011.
/s/ Jerome B. Zeldis
2011-06-24